Group One Trading
VCNX

Group One Trading’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Group One Trading’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-229
Closed -$2.13K – 8140
2023
Q4 		$2.13K Hold
229
– – ﹤0.01% 6805
2023
Q3 		$3.62K Buy
229
+214
+1,427% +$10.9K ﹤0.01% 6839
2023
Q2 		$1.14K Buy
15
+14
+1,400% +$1.17K ﹤0.01% 7235
2023
Q1 		$120 Buy
+1
New +$110 ﹤0.01% 7025
2022
Q3 		– Sell
-37
Closed -$8K – 8413
2022
Q2 		$8K Sell
37
-7
-16% -$1.79K ﹤0.01% 6899
2022
Q1 		$12K Buy
44
+38
+633% +$10.5K ﹤0.01% 7095
2021
Q4 		$1K Sell
6
-52
-90% -$18.8K ﹤0.01% 8054
2021
Q3 		$26K Sell
58
-71
-55% -$35.4K ﹤0.01% 7025
2021
Q2 		$76K Buy
129
+29
+29% +$15.3K ﹤0.01% 6216
2021
Q1 		$63K Buy
100
+98
+4,900% +$63K ﹤0.01% 6062
2020
Q4 		$1K Buy
+2
New +$837 ﹤0.01% 6367

Other funds holding VCNX

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Group One Trading's VCNX Position: Q4 2024 in Review

Group One Trading sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 67 shares — an estimated $231 sold.

Group One Trading first reported a position in VCNX in Q4 2021 and held it in 12 quarters. The position peaked at $13.5K in Q4 2022. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.

  • Group One Trading reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 67 Vaccinex, Inc. Common Stock shares in Q4 2024, an estimated $231.
  • Group One Trading first reported a position in Vaccinex, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Group One Trading's Vaccinex, Inc. Common Stock position peaked at $13.5K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.